Tirzepatide
Dual GIP/GLP-1 Agonist
Novel dual agonist of GIP and GLP-1 receptors. The simultaneous activation of two incretin pathways produces superior insulin sensitisation, metabolic improvement, and body composition effects compared to mono-agonists in research models.
Format
5mg / vial
Purity
>99.4%
Category
Performance
Storage
2–8 °C
Research Price
€159
5mg / vial
RESEARCH USE ONLY
This compound is sold exclusively for in-vitro laboratory research. It is not intended for human consumption, therapeutic use, or self-administration. You must be 18+ and a qualified researcher to purchase.
Complete Your Research with the Pen Kit
Precise, painless, repeatable. The clinical-grade injection pen with 32G ultra-fine needles, bacteriostatic water, and your choice of peptide — ready to use out of the box.
€189
View details →Documented Research Parameters
Research Dose
2.5–15 mg per week (escalating)
Frequency
Once weekly
Duration
12–72 weeks
Half-Life
~120 hours (5 days)
Route(s)
Subcutaneous
Solubility
Water
Reconstitution
2 ml bacteriostatic water per 5 mg vial
Key Research Findings
SURMOUNT-1 trial demonstrated 20.9% mean body weight reduction — the highest reported for a pharmacological agent at time of publication.
GIP receptor agonism enhances adipocyte lipid storage capacity, complementing GLP-1's central anorectic effects.
Tirzepatide's dual mechanism produces superior insulin sensitisation versus mono-GLP-1 agonists in head-to-head models.
Administration Reference
Subcutaneous administration into abdominal, thigh, or upper arm sites. Weekly injection with site rotation. Standard escalation: 2.5 mg/week for 4 weeks, then increasing by 2.5 mg every 4 weeks as tolerated, up to 15 mg/week maximum studied dose.
IMPORTANT RESEARCH DISCLAIMER
This compound is for in-vitro research and laboratory use only. It has not been evaluated or approved by any regulatory authority for human therapeutic use. It must not be used as a food, drug, or cosmetic. SYNTHEXA assumes no liability for misuse. Handle in accordance with Good Laboratory Practice.